Literature DB >> 18620828

Considerations on the physiopathological mechanism of inner ear damage induced by intravenous cocaine abuse: cues from a case report.

A Ciorba1, R Bovo, S Prosser, A Martini.   

Abstract

OBJECTIVE: Aim of the following paper is to discuss about the possible etiopathogenetic mechanisms of inner ear damage induced by cocaine abuse. Unfortunately the data concerning this topic are very limited; the authors are then presenting a literature review, also discussing the clinical presentation and the possible therapeutical approach of a clinical case of bilateral sudden sensorineural hearing loss following i.v. injection of cocaine. PATIENTS: Case report. INTERVENTION: A strictly audiological evaluation has been performed, in order to identify the cochlear lesion site(s) and to provide the best medical treatment.
CONCLUSIONS: To our knowledge, this is the first report of acute cocaine intoxication with sudden bilateral hearing loss. Further studies are required in order to understand the effects of these substances on the inner ear cells and metabolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620828     DOI: 10.1016/j.anl.2008.04.013

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  3 in total

1.  Mu-opioid receptor (MOR) expression in the human spiral ganglia.

Authors:  Kimanh D Nguyen; Donald Mowlds; Ivan A Lopez; Seiji Hosokawa; Akira Ishiyama; Gail Ishiyama
Journal:  Brain Res       Date:  2014-09-30       Impact factor: 3.252

2.  Illegal Drug Use and Risk of Hearing Loss in the United States: A National Health and Nutrition Examination Survey.

Authors:  Po-Ting Lin; I-Hsun Li; Hui-Wen Yang; Kuan-Wei Chiang; Chih-Hung Wang; Li-Ting Kao
Journal:  Int J Environ Res Public Health       Date:  2021-11-13       Impact factor: 3.390

3.  Brain stem evoked response audiometry of former drug users.

Authors:  Tainara Milbradt Weich; Tania Maria Tochetto; Lilian Seligman
Journal:  Braz J Otorhinolaryngol       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.